China Dihydroartemisinin Market Research Report 2017

December 2017 | 95 pages | ID: C08CDBD6727EN
QYResearch

Abstracts

The global Dihydroartemisinin market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Dihydroartemisinin development status and future trend in China, focuses on top players in China, also splits Dihydroartemisinin by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• Sanofi
• KPC Pharmaceuticals
• Guangxi Xiancaotang Pharmaceutical
• Guilin Pharmaceutical
• Kerui Nanhai Pharmaceutical
• Shanghai Natural Bio-engineering Co
• Novanat Bioresource
• Botanical Extracts EPZ Ltd

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into

• Pharmaceutical Grade
• Industrial Grade

On the basis of the end users/application, this report covers

• Malaria Treatment
• Scientific Research
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China Dihydroartemisinin Market Research Report 2017

1 DIHYDROARTEMISININ OVERVIEW

1.1 Product Overview and Scope of Dihydroartemisinin
1.2 Classification of Dihydroartemisinin by Product Category
  1.2.1 China Dihydroartemisinin Sales (K MT) Comparison by Type (2012-2022)
  1.2.2 China Dihydroartemisinin Sales (K MT) Market Share by Type in 2016
  1.2.3 Pharmaceutical Grade
  1.2.4 Industrial Grade
1.3 China Dihydroartemisinin Market by Application/End Users
  1.3.1 China Dihydroartemisinin Sales (K MT) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Malaria Treatment
  1.3.3 Scientific Research
  1.3.4 Others
1.4 China Dihydroartemisinin Market by Region
  1.4.1 China Dihydroartemisinin Market Size (Million USD) Comparison by Region (2012-2022)
  1.4.2 South China Dihydroartemisinin Status and Prospect (2012-2022)
  1.4.3 East China Dihydroartemisinin Status and Prospect (2012-2022)
  1.4.4 Southwest China Dihydroartemisinin Status and Prospect (2012-2022)
  1.4.5 Northeast China Dihydroartemisinin Status and Prospect (2012-2022)
  1.4.6 North China Dihydroartemisinin Status and Prospect (2012-2022)
  1.4.7 Central China Dihydroartemisinin Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Dihydroartemisinin (2012-2022)
  1.5.1 China Dihydroartemisinin Sales (K MT) and Growth Rate (%)(2012-2022)
  1.5.2 China Dihydroartemisinin Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 CHINA DIHYDROARTEMISININ MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Dihydroartemisinin Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Dihydroartemisinin Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Dihydroartemisinin Average Price (USD/MT) by Players/Manufacturers (2012-2017)
2.4 China Dihydroartemisinin Market Competitive Situation and Trends
  2.4.1 China Dihydroartemisinin Market Concentration Rate
  2.4.2 China Dihydroartemisinin Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Dihydroartemisinin Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA DIHYDROARTEMISININ SALES AND REVENUE BY REGION (2012-2017)

3.1 China Dihydroartemisinin Sales (K MT) and Market Share by Region (2012-2017)
3.2 China Dihydroartemisinin Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Dihydroartemisinin Price (USD/MT) by Regions (2012-2017)

4 CHINA '&B1&' SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2012-2017)'

4.1 China Dihydroartemisinin Sales (K MT) and Market Share by Type/ Product Category (2012-2017)
4.2 China Dihydroartemisinin Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Dihydroartemisinin Price (USD/MT) by Type (2012-2017)
4.4 China Dihydroartemisinin Sales Growth Rate (%) by Type (2012-2017)

5 CHINA '&B1&' SALES BY APPLICATION (2012-2017)'

5.1 China Dihydroartemisinin Sales (K MT) and Market Share by Application (2012-2017)
5.2 China Dihydroartemisinin Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 CHINA DIHYDROARTEMISININ PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Sanofi
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Dihydroartemisinin Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.1.4 Main Business/Business Overview
6.2 KPC Pharmaceuticals
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Dihydroartemisinin Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 KPC Pharmaceuticals Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Guangxi Xiancaotang Pharmaceutical
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Dihydroartemisinin Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Guilin Pharmaceutical
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Dihydroartemisinin Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Guilin Pharmaceutical Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Kerui Nanhai Pharmaceutical
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Dihydroartemisinin Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Shanghai Natural Bio-engineering Co
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Dihydroartemisinin Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Novanat Bioresource
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Dihydroartemisinin Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Novanat Bioresource Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Botanical Extracts EPZ Ltd
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Dihydroartemisinin Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Botanical Extracts EPZ Ltd Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  6.8.4 Main Business/Business Overview

7 DIHYDROARTEMISININ MANUFACTURING COST ANALYSIS

7.1 Dihydroartemisinin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Dihydroartemisinin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Dihydroartemisinin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Dihydroartemisinin Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA DIHYDROARTEMISININ MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 China Dihydroartemisinin Sales (K MT), Revenue (Million USD) Forecast (2017-2022)
11.2 China Dihydroartemisinin Sales (K MT) Forecast by Type (2017-2022)
11.3 China Dihydroartemisinin Sales (K MT) Forecast by Application (2017-2022)
11.4 China Dihydroartemisinin Sales (K MT) Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Dihydroartemisinin Sales (K MT) and Revenue (Million USD) Market Split by Product Type
Table Dihydroartemisinin Sales (K MT) by Application (2016-2022)
Figure Product Picture of Dihydroartemisinin
Table China Dihydroartemisinin Sales (K MT) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Dihydroartemisinin Sales Volume Market Share by Types in 2016
Figure Pharmaceutical Grade Product Picture
Figure Industrial Grade Product Picture
Figure China Dihydroartemisinin Sales (K MT) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Dihydroartemisinin by Application in 2016
Figure Malaria Treatment Examples
Table Key Downstream Customer in Malaria Treatment
Figure Scientific Research Examples
Table Key Downstream Customer in Scientific Research
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China Dihydroartemisinin Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Dihydroartemisinin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Dihydroartemisinin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Dihydroartemisinin Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Dihydroartemisinin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Dihydroartemisinin Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Dihydroartemisinin Sales (K MT) and Growth Rate (%)(2012-2022)
Figure China Dihydroartemisinin Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Dihydroartemisinin Sales of Key Players/Manufacturers (2012-2017)
Table China Dihydroartemisinin Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Dihydroartemisinin Sales Share (%) by Players/Manufacturers
Figure 2017 China Dihydroartemisinin Sales Share (%) by Players/Manufacturers
Table China Dihydroartemisinin Revenue by Players/Manufacturers (2012-2017)
Table China Dihydroartemisinin Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Dihydroartemisinin Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Dihydroartemisinin Revenue Market Share (%) by Players/Manufacturers
Table China Market Dihydroartemisinin Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Dihydroartemisinin Average Price of Key Players/Manufacturers in 2016
Figure China Dihydroartemisinin Market Share of Top 3 Players/Manufacturers
Figure China Dihydroartemisinin Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Dihydroartemisinin Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Dihydroartemisinin Product Category
Table China Dihydroartemisinin Sales (K MT) by Regions (2012-2017)
Table China Dihydroartemisinin Sales Share (%) by Regions (2012-2017)
Figure China Dihydroartemisinin Sales Share (%) by Regions (2012-2017)
Figure China Dihydroartemisinin Sales Market Share (%) by Regions in 2016
Table China Dihydroartemisinin Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Dihydroartemisinin Revenue Market Share (%) by Regions (2012-2017)
Figure China Dihydroartemisinin Revenue Market Share (%) by Regions (2012-2017)
Figure China Dihydroartemisinin Revenue Market Share (%) by Regions in 2016
Table China Dihydroartemisinin Price (USD/MT) by Regions (2012-2017)
Table China Dihydroartemisinin Sales (K MT) by Type (2012-2017)
Table China Dihydroartemisinin Sales Share (%) by Type (2012-2017)
Figure China Dihydroartemisinin Sales Share (%) by Type (2012-2017)
Figure China Dihydroartemisinin Sales Market Share (%) by Type in 2016
Table China Dihydroartemisinin Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Dihydroartemisinin Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Dihydroartemisinin by Type (2012-2017)
Figure Revenue Market Share of Dihydroartemisinin by Type in 2016
Table China Dihydroartemisinin Price (USD/MT) by Types (2012-2017)
Figure China Dihydroartemisinin Sales Growth Rate (%) by Type (2012-2017)
Table China Dihydroartemisinin Sales (K MT) by Applications (2012-2017)
Table China Dihydroartemisinin Sales Market Share (%) by Applications (2012-2017)
Figure China Dihydroartemisinin Sales Market Share (%) by Application (2012-2017)
Figure China Dihydroartemisinin Sales Market Share (%) by Application in 2016
Table China Dihydroartemisinin Sales Growth Rate (%) by Application (2012-2017)
Figure China Dihydroartemisinin Sales Growth Rate (%) by Application (2012-2017)
Table Sanofi Dihydroartemisinin Basic Information List
Table Sanofi Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Sanofi Dihydroartemisinin Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Sanofi Dihydroartemisinin Sales Market Share (%) in China (2012-2017)
Figure Sanofi Dihydroartemisinin Revenue Market Share (%) in China (2012-2017)
Table KPC Pharmaceuticals Dihydroartemisinin Basic Information List
Table KPC Pharmaceuticals Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure KPC Pharmaceuticals Dihydroartemisinin Sales (K MT) and Growth Rate (%)(2012-2017)
Figure KPC Pharmaceuticals Dihydroartemisinin Sales Market Share (%) in China (2012-2017)
Figure KPC Pharmaceuticals Dihydroartemisinin Revenue Market Share (%) in China (2012-2017)
Table Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Basic Information List
Table Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales Market Share (%) in China (2012-2017)
Figure Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Revenue Market Share (%) in China (2012-2017)
Table Guilin Pharmaceutical Dihydroartemisinin Basic Information List
Table Guilin Pharmaceutical Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Guilin Pharmaceutical Dihydroartemisinin Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Guilin Pharmaceutical Dihydroartemisinin Sales Market Share (%) in China (2012-2017)
Figure Guilin Pharmaceutical Dihydroartemisinin Revenue Market Share (%) in China (2012-2017)
Table Kerui Nanhai Pharmaceutical Dihydroartemisinin Basic Information List
Table Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales Market Share (%) in China (2012-2017)
Figure Kerui Nanhai Pharmaceutical Dihydroartemisinin Revenue Market Share (%) in China (2012-2017)
Table Shanghai Natural Bio-engineering Co Dihydroartemisinin Basic Information List
Table Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales Market Share (%) in China (2012-2017)
Figure Shanghai Natural Bio-engineering Co Dihydroartemisinin Revenue Market Share (%) in China (2012-2017)
Table Novanat Bioresource Dihydroartemisinin Basic Information List
Table Novanat Bioresource Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Novanat Bioresource Dihydroartemisinin Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Novanat Bioresource Dihydroartemisinin Sales Market Share (%) in China (2012-2017)
Figure Novanat Bioresource Dihydroartemisinin Revenue Market Share (%) in China (2012-2017)
Table Botanical Extracts EPZ Ltd Dihydroartemisinin Basic Information List
Table Botanical Extracts EPZ Ltd Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Figure Botanical Extracts EPZ Ltd Dihydroartemisinin Sales (K MT) and Growth Rate (%)(2012-2017)
Figure Botanical Extracts EPZ Ltd Dihydroartemisinin Sales Market Share (%) in China (2012-2017)
Figure Botanical Extracts EPZ Ltd Dihydroartemisinin Revenue Market Share (%) in China (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dihydroartemisinin
Figure Manufacturing Process Analysis of Dihydroartemisinin
Figure Dihydroartemisinin Industrial Chain Analysis
Table Raw Materials Sources of Dihydroartemisinin Major Players/Manufacturers in 2016
Table Major Buyers of Dihydroartemisinin
Table Distributors/Traders List
Figure China Dihydroartemisinin Sales (K MT) and Growth Rate (%) Forecast (2017-2022)
Figure China Dihydroartemisinin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Dihydroartemisinin Price (USD/MT) Trend Forecast (2017-2022)
Table China Dihydroartemisinin Sales (K MT) Forecast by Type (2017-2022)
Figure China Dihydroartemisinin Sales (K MT) Forecast by Type (2017-2022)
Figure China Dihydroartemisinin Sales Volume Market Share Forecast by Type in 2022
Table China Dihydroartemisinin Sales (K MT) Forecast by Application (2017-2022)
Figure China Dihydroartemisinin Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Dihydroartemisinin Sales Volume Market Share Forecast by Application in 2022
Table China Dihydroartemisinin Sales (K MT) Forecast by Regions (2017-2022)
Table China Dihydroartemisinin Sales Volume Share Forecast by Regions (2017-2022)
Figure China Dihydroartemisinin Sales Volume Share Forecast by Regions (2017-2022)
Figure China Dihydroartemisinin Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources